TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,886,522 | -67.0% | 3,096,474 | -2.0% | 0.01% | -66.7% |
| Q2 2023 | $78,484,762 | +56.8% | 3,159,612 | -5.1% | 0.02% | +50.0% |
| Q1 2023 | $50,058,399 | +23.2% | 3,328,351 | -3.1% | 0.01% | +25.0% |
| Q4 2022 | $40,617,714 | +55.2% | 3,433,450 | -22.4% | 0.01% | +33.3% |
| Q3 2022 | $26,179,000 | +47.1% | 4,422,122 | +5.6% | 0.01% | +50.0% |
| Q2 2022 | $17,797,000 | -53.5% | 4,187,444 | +4.2% | 0.00% | -42.9% |
| Q1 2022 | $38,235,000 | -52.7% | 4,020,476 | -5.4% | 0.01% | -46.2% |
| Q4 2021 | $80,762,000 | +54.0% | 4,250,670 | +169.8% | 0.01% | +44.4% |
| Q3 2021 | $52,440,000 | -68.2% | 1,575,729 | -62.9% | 0.01% | -66.7% |
| Q2 2021 | $164,768,000 | -20.8% | 4,247,677 | -1.6% | 0.03% | -27.0% |
| Q1 2021 | $208,068,000 | -18.7% | 4,316,761 | -12.2% | 0.04% | -21.3% |
| Q4 2020 | $255,825,000 | +189.1% | 4,917,833 | +48.7% | 0.05% | +161.1% |
| Q3 2020 | $88,497,000 | +5776.3% | 3,307,046 | +3019.2% | 0.02% | – |
| Q1 2018 | $1,506,000 | – | 106,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |